Canadian trial tests monkeypox drug in Non-Hospitalized patients
NCT ID NCT05534165
First seen Mar 05, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This study tests whether the drug tecovirimat helps people with monkeypox heal faster. It involves 120 non-hospitalized adults in Canada who have confirmed or suspected monkeypox. Half will get the drug, half a placebo, and researchers will track how quickly skin lesions resolve and whether it's feasible to run larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
St. Paul's Hospital, BC Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Conditions
Explore the condition pages connected to this study.